The latest update is out from MyndTec, Inc. ( (TSE:MYTC) ).
MyndTec Inc. has successfully completed the third tranche of its non-brokered private placement, raising $193,880, bringing the total proceeds from the offering to $472,042.25. The funds will be used for general corporate purposes, including working capital and sales and marketing. The units issued, including common shares and warrants, are subject to statutory hold periods and transfer restrictions. The participation of related parties in this private placement was exempt from certain regulatory requirements, and the completion of the transaction is pending final acceptance by the Canadian Securities Exchange.
More about MyndTec, Inc.
MyndTec is a CSE-listed medical technology company specializing in neurostimulation to restore function and improve treatment for individuals with central nervous system diseases, disorders, and damage, including Parkinson’s disease, Alzheimer’s disease, and stroke. The company has developed the MyndMove™ system, a non-invasive intervention that uses functional electrical stimulation and neuroplasticity mechanisms to stimulate the development of new neural pathways.
YTD Price Performance: -33.33%
Average Trading Volume: 5,765
Technical Sentiment Consensus Rating: Hold
Find detailed analytics on MYTC stock on TipRanks’ Stock Analysis page.